SAN CARLOS, Calif., Aug. 27 /PRNewswire-FirstCall/ -- NeurogesX, Inc. (Nasdaq: NGSX), a biopharmaceutical company focused on developing novel pain management therapies, announced today that it is scheduled to present at the 2007 NewsMakers in the Biotech Industry Conference on Thursday, September 6, 2007. Anthony DiTonno, President and Chief Executive Officer, and Stephen Ghiglieri, Chief Financial Officer, will be presenting.
Date: Thursday, September 6, 2007
Time: 2:00 p.m. ET
Place: Millennium Broadway Hotel, New York, NY
An audio Web cast of the Company's presentation will be available by going to the investor relations section of NeurogesX' Web site at http://www.neurogesx.com. A replay of the presentation will be available for 15 days.
About NeurogesX, Inc.
NeurogesX (Nasdaq: NGSX) is a biopharmaceutical company focused on
developing novel pain management therapies. Its initial focus is on chronic
peripheral neuropathic pain, including postherpetic neuralgia (PHN),
painful HIV-distal sensory polyneuropathy (HIV-DSP), and painful diabetic
neuropathy. NeurogesX's late stage product portfolio is led by product
candidate NGX-4010, a topical patch designed to manage pain associated with
peripheral neuropathic pain conditions, that the company believes offers
significant advantages over other pain therapies. Two Phase 3 clinical
trials with NGX-4010 have been completed and
|SOURCE NeurogesX, Inc.|
Copyright©2007 PR Newswire.
All rights reserved